Previous Article | Next Article ![]()
Journal of Virology, November 2000, p. 10034-10040, Vol. 74, No. 21
Department of Microbiology and
Immunology1 and Department of
Pathology,2 Louisiana State University
Health Sciences Center, Shreveport, Louisiana 71130
Received 16 March 2000/Accepted 9 August 2000
The CBA mouse model was used to investigate the immunopathology
induced in the lung by the pathogenic equine herpesvirus 1 (EHV-1)
strain RacL11 in comparison to infection with the attenuated vaccine
candidate strain KyA. Intranasal infection with KyA resulted in almost
no inflammatory infiltration in the lung. In contrast, infection with
the pathogenic RacL11 strain induced a severe alveolar and interstitial
inflammation, consisting primarily of lymphocytes, macrophages, and
neutrophils. Infection with either EHV-1 strain resulted in the
accumulation of similar numbers and ratios of CD4 and CD8 T lymphocytes
in the lung and bronchoalveolar lavage (BAL) fluid. Further analysis of
these T-cell populations revealed identical EHV-1-specific cytotoxic
T-lymphocyte responses. RNase protection analysis of RNA isolated from
the BAL fluid of RacL11-infected mice on day 3 postinfection revealed
much higher levels of RNA specific for macrophage inflammatory protein
1
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Severe Murine Lung Immunopathology Elicited by the Pathogenic
Equine Herpesvirus 1 Strain RacL11 Correlates with Early Production
of Macrophage Inflammatory Proteins 1
, 1
, and 2 and Tumor
Necrosis Factor Alpha
(MIP-1
), MIP-1
, and MIP-2 than were observed for
KyA-infected mice. Furthermore, significantly higher levels of
transcripts specific for tumor necrosis factor alpha were induced on
day 3 postinfection with RacL11 compared with KyA. These findings
suggest that the early production of proinflammatory beta chemokines
plays a major role in the severe, most often lethal, respiratory
inflammatory response induced by the pathogenic EHV-1 strain RacL11.
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130. Phone: (318) 675-5750. Fax: (318) 675-5764. E-mail: docall{at}lsuhsc.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»